The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
about
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesMeta-analysis of BRCA1 and BRCA2 penetranceFounder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancerLog odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencingBias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersGermline susceptibility to colorectal cancer due to base-excision repair gene defects.Population-Calibrated Gene Characterization: Estimating Age at Onset Distributions Associated With Cancer GenesCharacterization of BRCA1 and BRCA2 mutations in a large United States sampleA discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics servicesUsing lifetime risk estimates in personal genomic profiles: estimation of uncertaintyAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variationDifferences in reproductive risk factors for breast cancer in middle-aged women in Marin County, California and a sociodemographically similar area of Northern California.c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals.Second Primary Cancers After Primary Breast Cancer Diagnosis in Israeli Women, 1992 to 2006.Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".Autoantibodies to tumor-associated antigens in breast carcinoma.BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.MYC in breast tumor progressionMYC and Breast Cancer.APOE and Alzheimer disease: a major gene with semi-dominant inheritanceAdequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer.BRCA1 germline mutation and glioblastoma development: report of cases.Breast cancer risks and risk prediction models.A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer.Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian populationA diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancerNovel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations.The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.BRCA germline mutations in Jewish patients with pancreatic adenocarcinomaLarge family with both parents affected by distinct BRCA1 mutations: implications for genetic testingA rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencingProspective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.BRCA2 T2722R is a deleterious allele that causes exon skipping.Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer.Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.
P2860
Q24531993-ACCDF9AB-92FE-4CAA-A9EF-A0A785603FB8Q24654786-73998165-4FC5-4797-9414-9C961F6FF071Q24798248-7A7A5C2D-AC55-48CD-8B15-2911235082B8Q24802704-2B583339-5DE1-4486-BED5-748E3F7B8612Q26991615-A8D084E6-82E8-4385-98A7-D8E19A1B9951Q28085448-DF4C708A-0828-43E9-BFFD-37C5C2DFDDDEQ28254275-028C4526-F859-4B9B-8181-897467EF9C48Q28383948-0043ABB3-3D9A-4E8C-9217-4B70B48DD6B2Q28383993-5681E405-9B36-420E-B534-BD83DC926310Q28384136-7687AB83-84C9-45DF-A00F-5280A192E961Q28392540-E1748183-B100-4B2B-A78E-92B34C2A52DCQ28764361-B1AE429C-6808-4F47-A402-50C2BD2C7071Q30860043-37A8DCC3-9838-4870-8E8D-16FF9852A6B0Q31018068-31B375B8-30F3-4E29-BCA5-87D5BD1EFB06Q33355677-0D78810C-4C05-4696-B4A0-E75C1D0973F8Q33859784-4DD56C2B-1D9A-490C-A44A-843C3A1538A5Q34330301-5243E490-93E3-4CAE-B710-0967B44670B5Q34339160-237E7F9C-59FA-4018-BDEE-DE754327AC9FQ34480647-134E384D-A634-444B-902D-5340A093DC7EQ34524915-549CA53D-993B-4FDD-8F52-0E11A3192E33Q34972381-A8EFA1A5-F0F6-4544-9534-8E750C058FBBQ35181990-96DB61C8-9B8D-4B1E-AB63-313AB1B89FF4Q35219159-3926E0A2-646B-40A1-ACE6-F2851C63CDB4Q35226053-5FFD7FFC-1AAE-43FE-A196-1685EE694642Q35399596-5E5AD713-7960-4671-BC14-21859D269757Q35572946-ADF96279-87D1-461A-9B81-EBADC56D7975Q35645650-47B9F6EB-320A-46F8-A82A-863420E92A5DQ36138088-90701A4E-0AE2-4EA8-B83A-1BA7D5CB2659Q36230861-EEEDA2B2-C060-4A32-BA5E-B77EE7CE7C6AQ36615665-709B172C-E507-45A3-8DBA-1F98DDA564F4Q36660863-4231AF3E-F44C-4AD0-9411-DFBA954F4B80Q36854437-53C1E823-73B2-4799-BE7A-B7117FF8797AQ37123377-61FD165B-9769-4399-977A-3FA5741DA4C2Q37164443-888D222F-9F2F-44B2-ABE0-33B2EAD13DCAQ37185723-81BE19A0-F95B-46BC-ACA9-85967F8D66E8Q37219028-7C301764-1269-46B6-B2B2-F2B40878D8A7Q37269654-77D1F617-86B9-41F7-AF4F-9262CD8A4BFFQ37423574-4F808EBD-997A-4F0D-9C5A-5CDB09FCA02FQ37507426-8164E4DA-AC03-4FC4-92A3-B8DD8DA9A4ECQ40081082-D4AD25F1-D4FB-4E26-A7BE-8A8354DFEBCE
P2860
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The lifetime risks of breast c ...... of BRCA1 and BRCA2 mutations.
@ast
The lifetime risks of breast c ...... of BRCA1 and BRCA2 mutations.
@en
type
label
The lifetime risks of breast c ...... of BRCA1 and BRCA2 mutations.
@ast
The lifetime risks of breast c ...... of BRCA1 and BRCA2 mutations.
@en
prefLabel
The lifetime risks of breast c ...... of BRCA1 and BRCA2 mutations.
@ast
The lifetime risks of breast c ...... of BRCA1 and BRCA2 mutations.
@en
P2093
P1476
The lifetime risks of breast c ...... of BRCA1 and BRCA2 mutations.
@en
P2093
P304
P577
2001-05-01T00:00:00Z